Dan Ollendorf is Director of Value Measurement and Global Health Initiatives at the Center for the Evaluation of Value and Risk in Health (CEVR).  His research interests include expanding the use of health technology assessment in low- and middle-income economies, as well as refinement of value assessment tools in the US.  Prior to joining CEVR, Dr. Ollendorf was Chief Scientific Officer for the Institute for Clinical and Economic Review (ICER) for over 10 years, where he was responsible scientific oversight of all clinical and economic aspects of the health technology assessment process. 

Dr. Ollendorf holds a PhD in clinical epidemiology from the University of Amsterdam and an MPH from Boston University.  He is the current Chair of the Health Technology Assessment International Global Policy Forum and served on the US Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) from 2015-2019.  Dr. Ollendorf has authored over 100 articles in peer-review journals and is co-author of The Right Price: A Value-Based Prescription for Drug Costs (Oxford University Press).